Bringing together leading researchers in signal transduction from across Canada and abroad

Signalling in Normal and Cancer Cells Conference

The Marathon of Hope Cancer Centres Network and the Terry Fox Research Institute are happy to support the 12th Signalling in Normal and Cancer Cells Conference, which will be held in Banff, AB on April 23 - 27. The conference brings together leading researchers in signal transduction from across Canada and abroad, including a number of researchers supported by the Marathon of Hope Cancer Centres Network. 

Learn more about the event and register, here.

Visit event Website

 


About the Event

In each edition, the Conference on Signalling in Normal and Cancer Cells brings together leading researchers in signal transduction from across Canada and the world. These researchers are involved in various aspects of cell signalling research, from the membrane to the nucleus and from basic research to translational research.

The conference in a nutshell

  • Speakers and attendees from 20+ universities and research centres in Canada, the US, Europe, and other countries
  • 100 to 150 participants per edition
  • 60% Investigators, 40% trainees
  • 4 days
  • 7 sessions
  • 6 nutri break/coffee breaks
  • 32 speakers
  • 10 short talks / 3 Marathon of Hope Cancer Centres Network - MOHCCN Sessions
  •  4 poster sessions

With a history of almost 30 years in Canada, it is the premier venue for cell signalling researchers to connect and exchange ideas (and enjoy the sun and snow of the beautiful Rocky Mountains).

List of MOHCCN Speakers participating in the event

Enfu HuiApril 26: Immune regulation of cancer progression
Ian WatsonApril 26: Immune regulation of cancer progression
Janessa LaskinApril 25: Improving outcomes of hard-to-treat cancer with precision oncology
Dan RenoufApril 25: Improving outcomes of hard-to-treat cancer with precision oncology
Brad NelsonApril 26: Immune regulation of cancer progression
Marco MarraApril 26: Keynote
Trevor PughApril 25: Improving outcomes of hard-to-treat cancer with precision oncology
Nizar BahlisApril 25: Improving outcomes of hard-to-treat cancer with precision oncology
Daniela QuailApril 26: Immune regulation of cancer progression
Morag ParkApril 24: Signalling in the Tumor Microenvironment (Non-MOHCCN session)
André VeilletteApril 24: Signalling in the Tumor Microenvironment (Non-MOHCCN session)
Jim WoodgettApril 26: Kinases and Ras proteins (Non-MOHCCN session)